• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名脊髓损伤患者的难治性体位性低血压:用屈昔多巴治疗。

Refractory orthostatic hypotension in a patient with a spinal cord injury: Treatment with droxidopa.

作者信息

Canosa-Hermida Eva, Mondelo-García Cristina, Ferreiro-Velasco María Elena, Salvador-de la Barrera Sebastián, Montoto-Marqués Antonio, Rodríguez-Sotillo Antonio, Vizoso-Hermida José Ramón

机构信息

a Spinal Cord Injury Unit.

b Pharmacy Service, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade da Coruña (UDC) , Coruña , Spain.

出版信息

J Spinal Cord Med. 2018 Jan;41(1):115-118. doi: 10.1080/10790268.2016.1274093. Epub 2017 Jan 24.

DOI:10.1080/10790268.2016.1274093
PMID:28114866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5810796/
Abstract

CONTEXT

Orthostatic hypotension (OH) is a common complication in patients with a spinal cord injury, mainly affecting complete injuries above neurological level T6. It is generally more severe during the acute phase but can remain symptomatic for several years.

FINDINGS

A 65-year-old male with a grade ASIA A post-traumatic cervical spinal cord injury, at neurological level C4, presenting with symptomatic refractory OH. Increased blood pressure (BP) levels and an overall clinical improvement was observed after administering an increasing dose of droxidopa. Treatment was started at a dose of 100 mg twice daily (bid), one to be taken upon rising in the morning and another one in the afternoon, at least three hours before bedtime. According to the patient's symptomatic response, each individual dose was increased by 100 mg at 48-hour intervals. Both increased mean BP levels and a subjective symptomatic improvement were evidenced at a dose of 300 mg bid.

CLINICAL RELEVANCE

Treatment with droxidopa increases BP levels and improves symptoms related to refractory OH using all physical and pharmacological measures available. It could therefore constitute an effective alternative treatment for OH in patients with a spinal cord injury.

摘要

背景

直立性低血压(OH)是脊髓损伤患者的常见并发症,主要影响神经平面T6以上的完全性损伤。通常在急性期更为严重,但症状可能会持续数年。

研究结果

一名65岁男性,创伤后颈髓损伤,ASIA A级,神经平面C4,出现症状性难治性OH。在给予递增剂量的屈昔多巴后,观察到血压(BP)水平升高及整体临床改善。治疗开始时剂量为每日两次,每次100mg(bid),一次在早晨起床时服用,另一次在下午服用,至少在睡前三小时。根据患者的症状反应,每隔48小时将单次剂量增加100mg。在每日两次300mg的剂量时,平均BP水平升高及主观症状改善均得到证实。

临床意义

使用所有可用的物理和药物措施,屈昔多巴治疗可提高BP水平并改善与难治性OH相关的症状。因此,它可能成为脊髓损伤患者OH的一种有效替代治疗方法。

相似文献

1
Refractory orthostatic hypotension in a patient with a spinal cord injury: Treatment with droxidopa.一名脊髓损伤患者的难治性体位性低血压:用屈昔多巴治疗。
J Spinal Cord Med. 2018 Jan;41(1):115-118. doi: 10.1080/10790268.2016.1274093. Epub 2017 Jan 24.
2
L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.L-苏糖型二羟基苯丝氨酸(L-苏糖型-DOPS;屈昔多巴)用于治疗神经源性直立性低血压:一项针对多系统萎缩和单纯自主神经功能衰竭的多国、多中心、剂量范围研究。
Clin Auton Res. 2001 Aug;11(4):235-42. doi: 10.1007/BF02298955.
3
Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury.脊髓损伤低血压个体中 L-苏-3,4-二羟基苯丝氨酸(Droxidopa)的血液动力学效应。
Arch Phys Med Rehabil. 2013 Oct;94(10):2006-12. doi: 10.1016/j.apmr.2013.03.028. Epub 2013 Apr 18.
4
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.滴定屈昔多巴以最大化帕金森病合并神经源性直立性低血压患者的症状获益。
Clin Auton Res. 2017 Jul;27(Suppl 1):15-16. doi: 10.1007/s10286-017-0430-x. Epub 2017 Jul 11.
5
Droxidopa (Northera) for neurogenic orthostatic hypotension.屈昔多巴(诺特罗)用于神经源性直立性低血压。
Med Lett Drugs Ther. 2015 Jun 22;57(1471):92-3.
6
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.调整屈昔多巴治疗帕金森病患者神经源性直立性低血压
Clin Auton Res. 2017 Jul;27(Suppl 1):17-19. doi: 10.1007/s10286-017-0431-9. Epub 2017 Jun 19.
7
Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.卧位血浆去甲肾上腺素可预测神经源性直立性低血压患者对屈昔多巴的升压反应。
Neurology. 2018 Oct 16;91(16):e1539-e1544. doi: 10.1212/WNL.0000000000006369. Epub 2018 Sep 19.
8
Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.伴有症状的神经源性直立性低血压对屈昔多巴有反应的患者的随机撤药研究。
Hypertension. 2015 Jan;65(1):101-7. doi: 10.1161/HYPERTENSIONAHA.114.04035. Epub 2014 Oct 27.
9
Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.多佐胺治疗淀粉样变轻链淀粉样变性致难治性神经源性直立性低血压和反射性心动过缓:1 例报告。
J Med Case Rep. 2020 Jun 20;14(1):73. doi: 10.1186/s13256-020-02405-w.
10
Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.在一名多系统萎缩患者中定义用屈昔多巴成功治疗神经源性直立性低血压。
Clin Auton Res. 2017 Jul;27(Suppl 1):21-23. doi: 10.1007/s10286-017-0432-8. Epub 2017 Jun 19.

引用本文的文献

1
Recurrent syncope secondary to autonomic dysfunction in spinal cord injury: a case report.脊髓损伤继发自主神经功能障碍所致反复晕厥:病例报告。
Spinal Cord Ser Cases. 2023 Jun 30;9(1):23. doi: 10.1038/s41394-023-00585-3.
2
Use of droxidopa for blood pressure augmentation after acute spinal cord injury: case reports.急性脊髓损伤后使用屈昔多巴提升血压:病例报告
Acute Crit Care. 2025 Feb;40(1):138-143. doi: 10.4266/acc.2021.01662. Epub 2022 Dec 7.
3
HSP70 alleviates spinal cord injury by activating the NF-kB pathway.热休克蛋白 70 通过激活 NF-κB 通路缓解脊髓损伤。
J Musculoskelet Neuronal Interact. 2021 Dec 1;21(4):542-549.

本文引用的文献

1
Droxidopa in neurogenic orthostatic hypotension.屈昔多巴治疗神经源性直立性低血压。
Expert Rev Cardiovasc Ther. 2015;13(8):875-91. doi: 10.1586/14779072.2015.1057504. Epub 2015 Jun 19.
2
Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.伴有症状的神经源性直立性低血压对屈昔多巴有反应的患者的随机撤药研究。
Hypertension. 2015 Jan;65(1):101-7. doi: 10.1161/HYPERTENSIONAHA.114.04035. Epub 2014 Oct 27.
3
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.多巴酚丁胺治疗神经源性直立性低血压的随机、安慰剂对照、3 期临床试验。
Neurology. 2014 Jul 22;83(4):328-35. doi: 10.1212/WNL.0000000000000615. Epub 2014 Jun 18.
4
Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury.脊髓损伤低血压个体中 L-苏-3,4-二羟基苯丝氨酸(Droxidopa)的血液动力学效应。
Arch Phys Med Rehabil. 2013 Oct;94(10):2006-12. doi: 10.1016/j.apmr.2013.03.028. Epub 2013 Apr 18.
5
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.关于直立性低血压、神经介导性晕厥和姿势性心动过速综合征定义的共识声明。
Clin Auton Res. 2011 Apr;21(2):69-72. doi: 10.1007/s10286-011-0119-5.
6
Effects of midodrine hydrochloride on blood pressure and cerebral blood flow during orthostasis in persons with chronic tetraplegia.盐酸米多君对慢性四肢瘫患者直立位时血压和脑血流的影响。
Arch Phys Med Rehabil. 2010 Sep;91(9):1429-35. doi: 10.1016/j.apmr.2010.06.017.
7
L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.左旋二羟基苯丝氨酸(屈昔多巴)治疗直立性低血压:欧洲经验
Clin Auton Res. 2008 Mar;18 Suppl 1:25-9. doi: 10.1007/s10286-007-1005-z. Epub 2008 Mar 27.
8
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.左旋二羟基苯丝氨酸(屈昔多巴):神经源性直立性低血压的一种新疗法:美国的经验
Clin Auton Res. 2008 Mar;18 Suppl 1:19-24. doi: 10.1007/s10286-007-1002-2. Epub 2008 Mar 27.
9
Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure.一氧化氮合酶抑制对血压的直接及反射性作用
Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H190-7. doi: 10.1152/ajpheart.00366.2007. Epub 2007 Oct 26.
10
The clinical problems in cardiovascular control following spinal cord injury: an overview.脊髓损伤后心血管控制方面的临床问题:综述
Prog Brain Res. 2006;152:223-9. doi: 10.1016/S0079-6123(05)52014-4.